Playback speed
10 seconds
Tocilizumab in Systemic Sclerosis: FocuSSed Trial Study Discussion
256 views
September 23, 2021
Liudmila Kastsianok, MD and Rebecca Keith, MD of National Jewish Health discuss the article “Tocilizumab ...
read more ↘ in systemic sclerosis: a randomized, double-blind, placebo-controlled, phase 3 trial” during the 30-minute webinar of the ILD Journal Club on September 14, 2021. Article summary: https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/ild-article-summary-focussed-vol1_issue2.aspx
↖ read less
read more ↘ in systemic sclerosis: a randomized, double-blind, placebo-controlled, phase 3 trial” during the 30-minute webinar of the ILD Journal Club on September 14, 2021. Article summary: https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/ild-article-summary-focussed-vol1_issue2.aspx
↖ read less
Comments 0
Login to view comments.
Click here to Login